Dr. Evans is a Professor of Medicine at the University of Washington. She is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Hospice and Palliative Medicine. Her interests focus on the translation of evidence into clinical practice, particularly in sepsis, and on building the capacity to prepare for and respond to high consequence infectious diseases.

She joined the ABIM Critical Care Medicine Board in 2014 and serves as chair. She served on the Council of the Society of Critical Care Medicine (SCCM) for six years and chairs the SCCM Discover Clinical Research Network. She is a member of the National Emerging Special Pathogens Training and Education Center.  

Dr. Evans earned her medical degree at the University of Michigan and completed her internal medicine residency at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a Master of Science in Epidemiology at the University of Washington.

As of September 2024, Dr. Evans reported the following external relationships:

Dr. Evans serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• Centers for Disease Control and Prevention, Member, Healthcare Infection Control Practices Advisory Committee, without compensation. 

Grant funding for salary support, research expenses and staff, paid to the University of Washington Medical Center, from the following organizations:

• U.S. Department of Health and Human Services (HHS), subcontractor for project funded by HHS Administration for Strategic Preparedness and Response (ASPR).
• National Institutes of Health, serving as a coinvestigator on a study of approaches to improving sepsis care, receiving funding for salary support. 

Dr. Dingfield is an Assistant Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania, Director of Palliative Care Education for the University of Pennsylvania Health System and Program Director of the Hospice and Palliative Medicine Fellowship at the University of Pennsylvania in Philadelphia. She is ABIM Board Certified in Internal Medicine and Hospice and Palliative Medicine. Her academic focus is on medical education, including curricular innovation and assessment in competency-based education programs. She is the Chair of the Hospice and Palliative Medicine Advisory Committee.

Dr. Dingfield serves on the American Academy of Hospice and Palliative Medicine (AAHPM) Fellowship Training Committee and the AAHPM Assessment Task Force. She has previously served on Test Materials Development Committees for the National Board of Medical Examiners.

Dr. Dingfield graduated from the University of Michigan Medical School in Ann Arbor. She completed her internal medicine-pediatrics residency at the Hospital of the University of Pennsylvania-Children’s Hospital of Philadelphia, and her hospice and palliative medicine fellowship at the University of Pennsylvania Health System. She holds a master’s degree in education from the University of Pennsylvania Graduate School of Education.

As of April 2024, Dr. Dingfield reported no ongoing external relationships.

Dr. Bonura is an Associate Professor of Medicine and Program Director of the Infectious Disease Fellowship at Oregon Health & Science University (OHSU), as well as Director of the Microbiology and Immunology Thread for Undergraduate Medical Education. She serves as Chair of the Education Committee and Vice-Chair of the Infectious Diseases Society of America’s Medical Education Community of Practice. She is the Chair of the ABIM Infectious Disease Board.

She is also one of the founding members of the Educators' Collaborative which brings together faculty from all schools at OHSU (Medicine, Dentistry, Pharmacy, Nursing and Public Health) dedicated to education and furthering this mission at OHSU. In 2019 she became a co-director for the Education Scholars Program, a year-long course dedicated to training the next generation of scholars in health sciences education.

Dr. Bonura received her medical degree from Georgetown University in 2006. Following medical school, she completed her internship and residency at the Hospital of the University of Pennsylvania and New York University where she was also named chief resident. She completed a second fellowship at OHSU in internal medicine and completed her master's degree in clinical research with a focus on medical education methods and outcomes in the undergraduate and graduate settings. Subsequently, Dr. Bonura completed fellowship training at OHSU. She is ABIM Board Certified in Internal Medicine and Infectious Disease.

As of September 2024, Dr. Bonura reported the following external relationships:

Dr. Bonura serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• The Infectious Diseases Society of America, Board of Directors, without compensation
• The National Board of Medical Examiners, IRC Committee Member, receiving reimbursement for travel expenses and honoraria.

Dr. DeVault is a Professor and Chair of the Department of Medicine, and a member of the Executive Operating Team at the Mayo Clinic Florida. He is ABIM Board Certified in Internal Medicine and Gastroenterology. He is the Chair of the ABIM Gastroenterology Board.

Prior to becoming Chair of Medicine, Dr. DeVault was Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic Florida. Dr. DeVault is a fellow and past president of the American College of Gastroenterology. He is also a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy, and a fellow of the American College of Physicians.

Dr. DeVault conducts research on disorders affecting all aspects of the esophagus and has written more than 250 book chapters, abstracts, editorials and original articles on subjects ranging from the treatment of GERD, dysphagia, esophagitis and Barrett's esophagus to laparoscopic anti-reflux surgery and managed care issues in the treatment of GERD. He also has an interest in gastrointestinal health developing nations, improving professionalism in both trainees and practicing physicians and in the development of a diverse and effective healthcare work force.

He received his undergraduate degree from the University of Tennessee and his medical degree from the Bowman Gray School of Medicine at Wake Forest University. He completed his internship and residency in internal medicine at Vanderbilt University and completed a combined clinical and research fellowship at Jefferson Medical College.

As of September 2024, Dr. DeVault reported no ongoing external relationships.

Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, Minnesota. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. Previously, Dr. Gertz served as Treasurer for the International Myeloma Society and President of Mayo Staff Officers and Councilors. He also formerly chaired the Mayo Personnel Committee. He is the Chair of the ABIM Hematology Board.

Dr. Gertz has been recognized as a Mayo Distinguished Clinician and in 2014 received the Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström's Macroglobulinemia. He is recognized for contributions in amyloidosis and Waldenström's macroglobulinemia. He has authored more than 500 peer-reviewed publications in the field and is a frequently invited speaker across the country.

Dr. Gertz is a Master of the American College of Physicians. His undergraduate degree was awarded with highest distinction from Northwestern University, where he graduated Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola University Chicago’s Stritch School of Medicine in Maywood, Illinois, where he was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago where he was twice voted Resident of the Year.

As of September 2024, Dr. Gertz reported the following external relationships:

Research-related consulting for the following companies, receiving reimbursement for travel expenses and honoraria:  

• AbbVie, receiving honoraria.
• Ackea Therapeutics, receiving honoraria.
• Alexion, receiving honoraria.
• Alnylam Pharmaceuticals, receiving honoraria.
• AstraZeneca, receiving honoraria.
• Dava Oncology, receiving honoraria.
• Janssen, receiving honoraria.
• Johnson & Johnson, receiving honoraria.
• Medscape Education, receiving honoraria.
• Prothena, receiving reimbursement for travel expenses.
• Sanofi, receiving honoraria. 

Industry-supported continuing medical education supported by the following, with compensation as listed:

• Alnylam, receiving honoraria.  

Teaching in industry-sponsored satellite symposia with funding from the following company, with compensation as listed:  

• Johnson & Johnson, receiving honoraria.

Dr. Kazi is the Vice Chair of Education for the Department of Internal Medicine and a Professor of Medicine in the Division of Rheumatic Diseases at the University of Texas (UT) Southwestern Medical Center in Dallas. He is also the Director of the Internal Medicine Residency Training Program at UT Southwestern. Dr. Kazi is the Chair of the ABIM Rheumatology Board. He is ABIM Board Certified in Internal Medicine and Rheumatology.

Dr. Kazi previously served as the Chair of the Registries and Health Information Technology Committee of the American College of Rheumatology overseeing the development of the RISE registry. Dr. Kazi continues to lead efforts in rheumatology to promote improvement in the delivery of health care through the principles of co-production.

Dr. Kazi earned his medical degree from Dow Medical College in Karachi, Pakistan, and completed his residency, chief residency and fellowship in rheumatology at the University of Texas Health Science Center in Houston.

As of August 2024, Dr. Kazi reported no ongoing external relationships. 

Dr. Konadu is a general gastroenterologist and consultant for the multi-specialty group Huguley Medical Associates in Burleson, Texas. Prior to her current position, she served as faculty and consultant in gastroenterology with Duke University Medical Center in Durham, North Carolina, and Duke Raleigh Hospital in Raleigh, North Carolina. She is ABIM Board Certified in Internal Medicine and Gastroenterology.

She serves as a member of the ABIM Gastroenterology Board and on the American Gastroenterology Association's international committee. She also serves on the board and as secretary for the West African Institute for Liver and Digestive Diseases. She was honored by her colleagues as a Tarrant County Top Doctor in Gastroenterology 2020.
Her main clinical interests are in colon cancer prevention and irritable bowel syndrome. She has a passion for global health and some of her most esteemed experiences include her time educating and observing in Beijing and Ghana.

She received her bachelor's degree from the University of Texas at Austin and obtained her medical degree from the University of Texas Southwestern Medical Center in Dallas. She completed both her residency and fellowship at Duke University Medical Center in Durham, North Carolina.

As of August 2024, Dr. Konadu reported no ongoing external relationships. 

Mr. Milan is a recognized national and global expert and advocate on HIV. He has been living with HIV for over four decades. He is CEO Emeritus of AIDS United, having served nine years until July 2025 as its President and CEO, leading that national organization’s work on HIV policy, grantmaking and capacity building. He previously served two terms on the ABIM Infectious Disease Board.

Mr. Milan is a lawyer whose career includes leading HIV programs and organizations at the national, regional and global levels. He has addressed millions across the U.S. and Africa in keynotes, presentations and sermons. He serves currently on the Presidential Advisory Council on HIV/AIDS (PACHA), on the HIV Leadership Advisory Council for the U.S. Business Action to End HIV, on the board of AVAC (AIDS Vaccine Advocacy Coalition) and on the Practice Advisory Committee for the UNC Gillings School of Global Public Health. He served for 11 years until 2024 on the Scientific Advisory Board for the President’s Emergency Plans for AIDS Relief (PEPFAR).

He is the immediate past board chair of Funders Concerned About AIDS (FCAA) and board chair emeritus of the Black AIDS Institute. Mr. Milan was vice president for 15 years at two federal public health contractor firms and served at the appointment of the Secretary of Health and Human Services for five years as co-chair of the CDC/HRSA Advisory Committee on HIV and STD (CHAC). Mr. Milan is former AIDS Director for Philadelphia and a former Philadelphia Deputy City Solicitor, and he served six years as Chief of Staff to the president of Temple University.

In addition, he is past president of the National Episcopal AIDS Coalition and the Philadelphia AIDS Consortium. His many honors for his work in HIV have come from the American Bar Association, HRSA, POZ Magazine and the Association of Nurses in AIDS Care. In 2023, he received the Distinguished Alumni Award from the Association of Black Princeton Alumni, and in 2020 an honorary Doctorate of Humane Letters from the Virginia Theological Seminary.

Mr. Milan is a graduate of Princeton University and the New York University School of Law.

As of June 2025, Dr. Milan reported the following external relationships:

Mr. Milan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed: 

• AIDS United, Chief Executive Officer Emeritus, receiving retirement compensation.
• AIDS Vaccine Advocacy Coalition, Member of the Board of Directors, without compensation.
• Funders Concerned About AIDS, Chair of the Board, without compensation. 

Mr. Milan also serves on the scientific advisory board for the President’s Emergency Plan for AIDS Relief and the Presidential Advisory Council on HIV/AIDS.  

Ms. Morath is an international consultant in patient safety and healthcare quality leadership. Her work focuses on creating cultures of safety and designing reliability into clinical practice and the structures and mechanisms that support patient care. She is noted for her work in promoting workforce engagement and interdisciplinary alignment, and patient, family and community advocacy.

Ms. Morath has served in executive positions and academic appointments at the University of Cincinnati, Brown University and Vanderbilt University Academic Medical Centers. Her executive experience also includes Children's Hospitals and Clinics of Minnesota; Allina Health System; and founding the Hospital Quality Institute, supporting more than 400 California hospitals and health systems. She is a founding and current member of the Lucian Leape Institute of the National Patient Safety Foundation and serves as faculty at the Institute for Healthcare Improvement.

Ms. Morath served as a member of the Board of Commissioners of the Joint Commission. She holds current appointments on multiple governing and advisory boards, including the Collaborative for Accountability and Improvement, the Center for Scholarship Quality and Patient Safety, the University of Washington School of Medicine, MedStar Quality and Patient Safety Institute Advisory Board and the Board of Trust, Virginia Mason Medical Center and Health Care System.

She was the inaugural recipient of the John Eisenberg Award for Individual Lifetime Achievement in Patient Safety from the National Quality Forum and the Joint Commission. In 2018, she received the Beau Biden Humanitarian Award from the Patient Safety Movement Foundation. Of more than 50 published works, she has authored two books: “Do No Harm” and “The Quality Advantage” and contributed to six major reports from the Lucian Leape Institute on topics of transforming health care.

Ms. Morath earned her master's degree in nursing from the University of California, San Francisco and her undergraduate degree from the University of Michigan, Ann Arbor.

As of April 2025, Ms. Morath reported the following external relationships:

Ms. Morath serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• The Jewish Healthcare Foundation, Member of WHAM Global Advisory Board, without compensation. 

Dr. Nair is the Physician-in-Chief of the Lehigh Valley Cancer Institute (LVCI) in Allentown, Pennsylvania, and leads the health network’s academic programs. Dr. Nair is the Medical Director of the LVCI membership in the Memorial Sloan Kettering Cancer Center Alliance and has practiced oncology in the community setting for 27 years. He is the initial holder of the Auxiliary of Lehigh Valley Hospital Endowed Chair in Cancer. He is the Chair of the ABIM Medical Oncology Board and Council Director to the ABIM Board of Directors. He is ABIM Board Certified in Internal Medicine and Medical Oncology.

With clinical expertise in melanoma, kidney cancer and immunotherapy, Dr. Nair’s focus is to provide the highest-quality cancer care, including standard and research treatments. He leads a variety of clinical trials at Lehigh Valley Health Network (LVHN) to provide leading-edge options to patients. He leads the high-dose interleukin-2 program at LVHN for advanced melanoma and kidney cancer. Dr. Nair started the hematology/oncology fellowship at LVHN and served as the initial Program Director.

Dr. Nair has been a site principal investigator in the National Cancer Institute (NCI) Cooperative Group Program for over 25 years and was the first Chair of the NCI Early Phase Central Institutional Review Board. He has been a site principal investigator of over 40 T-cell checkpoint inhibitor trials at LVCI.

Dr. Nair received his medical degree from Jefferson Medical College in Philadelphia. He completed his residency at Geisinger Medical Center in Danville, Pennsylvania, and his fellowship at the University of Pittsburgh.

As of May 2025, Dr. Nair reported the following external relationships:

Funding for clinical trial support accrual, paid to Lehigh Valley Health Network, from the following companies:

• Bristol-Myers Squibb, serving as local hospital principal investigator of multicenter immunotherapy clinical trial.
• Elicio Therapeutics, serving as local principal investigator of multicenter vaccine study in pancreatic cancer, subsite of Memorial Sloan Kettering.
• Strata Oncology, serving as local hospital principal investigator for genomic testing and clinical trials. 

Dr. O'Neil is a partner at Wilmington Health, a multispecialty group in Wilmington, North Carolina. He served in a variety of roles while on active duty including chief medical resident; Chair, Critical Care Medicine; Pulmonary Division Chief; Pulmonary and Critical Care Fellowship Program Director; Navy specialty leader for Pulmonary/Critical Care Medicine and Graduate Medical Education Director for the National Naval Medical Center.

Dr. O’Neil previously served on the ABIM Pulmonary Disease Board. He is active in clinical practice guideline development with the American College of Chest Physicians and in respiratory care education through the Commission on Accreditation for Respiratory Care (CoARC).

Dr. O’Neil holds an undergraduate degree in chemical engineering from the University of Delaware, a medical degree from Jefferson Medical College in Philadelphia and a master's in healthcare administration from the University of North Carolina at Chapel Hill. He completed his residency and fellowship training at the Naval Hospital in Portsmouth, Virginia. He is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.

As of September 2024, Dr. O’Neil reported the following external relationships:

Dr. O’Neil serves in significant roles with the following organizations, receiving reimbursement or compensation as listed: 

• The American College of Chest Physicians, Past Chair Guidelines Committee, receiving reimbursement for travel expenses.
• The Committee on Accreditation for Respiratory Care, Board and Executive Committee Member, serving as President, receiving reimbursement for travel expenses. 

Dr. Rodriguez is the Director of the Hospital and Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington. As a clinician scholar, his academic career focused on nephrology fellowship education along with scholarly work on issues related to vulnerable populations. He is the Chair of the ABIM Nephrology Board.

Dr. Rodriguez is the Chair of the Veteran Affairs Nephrology Field Advisory Board. He also served on the American Society of Nephrology Training Program Director’s Executive Committee. He is ABIM Board Certified in Internal Medicine and Nephrology.

Dr. Rodriguez attended Stanford University and earned his medical degree at the CDU/UCLA Medical Education Program at the University of California, Los Angeles. He completed his internal medicine residency at California Pacific Medical Center in San Francisco, and his nephrology fellowship training at the University of California, San Francisco. 

As of August 2024, Dr. Rodriguez reported the following external relationships:

Dr. Rodriguez serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

• U.S. Department of Veteran Affairs, Chair, Kidney Medicine Field Advisory Board, without compensation. 

Dr. Russo, ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey. Dr. Russo previously served on the ABIM Cardiovascular Test-Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission. She is the Chair of the ABIM Cardiovascular Board.

She is past president of the Heart Rhythm Society (HRS), current member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardio-Obstetrics Council. She previously served on or chaired multiple ACC, AHA and HRS committees, subcommittees and working groups. In addition, she has served as co-chair or member on several guideline and consensus documents, as well as Appropriate Use criteria writing groups. She also serves on editorial boards for several peer-reviewed journals and is a current Associate Editor for Circulation: Arrhythmia and Electrophysiology. She has served on steering committees, events committees and data safety monitoring committees for several clinical trials. Her areas of research interest include implantable cardioverter defibrillators, atrial fibrillation therapies, sex differences in arrhythmias and the role of digital health in arrhythmia management.

Dr. Russo earned a Bachelor of Science in Microbiology at the University of Rochester and a medical degree at the SUNY Downstate Health Sciences University. She completed an internal medicine residency at Drexel University College of Medicine (then the Medical College of Pennsylvania) in Philadelphia and fellowships in cardiovascular disease and electrophysiology at the University of Medicine and Dentistry of New Jersey. 

As of October 2024, Dr. Russo reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:

• Abbott
• Bayer
• Medtronic

Service on data and safety monitoring boards for the following companies, with honoraria:

• Biosense Webster Inc.

Service on a research-related steering committee or advisory board for the following companies, without compensation:

• Abbott
• AtriCure
• Bayer
• Biotronik
• Medtronic
• PaceMate 

Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

• Medtronic
• Sanofi
• Bristol-Myers Squibb
• Boston Scientific 

Work as an author or editor for the following companies, with compensation as listed:

• UpToDate, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy.

Dr. Sehgal is a nationally recognized geriatric medicine clinician-educator, developer of innovative educational programming and leader of interprofessional teams. She currently serves as the Program Director for the Geriatric Medicine Fellowship at the Cleveland Clinic Florida and is a Clinical Affiliate Professor at Florida Atlantic University (FAU) Schmidt College of Medicine. She is board certified by the American Board of Family Medicine in Family Medicine and Geriatric Medicine. She previously served as a member of the ABIM Geriatric Medicine Board.

Dr. Sehgal is the Chair of the American Geriatrics Society (AGS) Teachers' Section and an Associate Editor for the Journal of the American Geriatrics Society, Education and Training Section, and the Teaching and Learning lead for Aquifer Geriatrics, the AGS National Online Curriculum, a role in which she works to teach others how to enhance curricula across the country. In 2020, she was awarded the AGS Educator of the Year Award for her efforts to advance person-centered care and geriatrics education at both local and national levels.

Over the course of her career, Dr. Sehgal has been a principal and co-investigator on multiple grant-funded projects totaling more than $5 million. In 2010, she was awarded a prestigious Geriatric Academic Career Award from the U.S. Bureau of Health Professions. Dr. Sehgal is a champion of providing person-centered care ensuring the best quality of life for her older adult patients while maintaining their safety and independence.

Dr. Sehgal attended college and medical school at the University of South Alabama. She completed her residency at Tallahassee Memorial's Family Medicine Residency Program, her geriatric medicine fellowship at the University of Cincinnati and faculty development fellowship at the University of North Carolina at Chapel Hill. 

As of April 2025, Dr. Sehgal reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

• Wiley-Blackwell, receiving compensation as Section Editor of The Journal of the American Geriatrics Society. 

Dr. Stansbury is an Associate Professor of Medicine and Director of the West Virginia University (WVU) Sleep Evaluation Center in Morgantown, West Virginia. He is also the Sleep Medicine Fellowship Program Director at WVU. He is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He is the Chair of the Sleep Medicine Advisory Committee.

He is an active member of the American Thoracic Society and the American Academy of Sleep Medicine and has served in multiple leadership roles including as committee chair for these societies. He is President of the West Virginia Sleep Society and an active member of the West Virginia Rural Health Association.

His research has involved team science and collaboration across multiple institutions. His interest and investigations broadly focus on three main areas: rural health inequity, novel approaches to the diagnosis and management of sleep apnea, and the physiology of occupational lung disease. Dr. Stansbury has published multiple research and review articles in these domains and multiple book chapters focused on sleep medicine and occupational lung disease.

Dr. Stansbury earned his medical degree at WVU School of Medicine and completed his internal medicine residency at the University of Kentucky College of Medicine in Lexington, Kentucky. He completed his pulmonary and critical care fellowship at WVU and his sleep medicine fellowship at the University of Pittsburgh School of Medicine in Pennsylvania.

As of May 2025, Dr. Stansbury reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to West Virginia University, from the following nonprofit healthcare-related organizations:

• The American Thoracic Society, receiving grant funding for American Thoracic Society Vaccine Initiative.
• The National Institutes of Health/National Heart, Lung & Blood Institute, receiving grant funding supporting work to improve sleep apnea care disparity in rural communities. 

Dr. Tanoue is ABIM Board Certified in Internal Medicine, Pulmonary Diseases and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at the Yale School of Medicine. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale New Haven, co¬directs the Yale Thoracic Oncology Program and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology. She is the Chair of the ABIM Pulmonary Disease Board.

Dr. Tanoue is Chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing board of Yale Medicine, and as immediate past-president of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.

Dr. Tanoue received a bachelor’s degree from Harvard University and medical degree from the Yale School of Medicine. She completed internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale New Haven Hospital. Dr. Tanoue received a master's degree in business administration from the Yale School of Management.

As of September 2024, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

• UpToDate, receiving compensation for authorship. 

Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

• American College of Chest Physicians, Board of Regents, without compensation.

Dr. Twining is an ABIM Board Certified endocrinologist and Medical Director at the Maine Medical Partners Center for Endocrinology and Diabetes, a group of eight endocrinologists in Scarborough, Maine. She practices general endocrinology with a focus on thyroid disease, metabolic bone disease and transitional care. Additionally, Dr. Twining is an Assistant Professor of Medicine at Tufts School of Medicine and teaches Tufts medical students and residents at Maine Medical Center, where she also serves as an advisor to internal medicine-pediatrics residents. She is the Chair of the ABIM Endocrinology, Diabetes and Metabolism Board.

She has been a member of the American Association of Clinical Endocrinologists (AACE) board of directors since 2015. She served previously as AACE's representative to the Young Physicians Section of the American Medical Association and as the Fellow-in-Training Representative to the Board of Directors. She also served on the board of the New England Chapter of AACE and was its president in 2013-2014. She has served on many AACE committees, including Endocrine Training Support, Socioeconomics, Chapters, Membership, Pediatric Endocrinology, and Endocrine University and the Task Force on Women in Endocrinology, among others.

Dr. Twining has an Artium Baccalaureus from Harvard College and a medical degree from Duke University School of Medicine. She completed a combined internal medicine-pediatrics residency at Yale University followed by an endocrinology fellowship at the University of South Carolina.

As of October 2024, Dr. Twining reported no ongoing external relationships.

Dr. Wardrop is a career clinician-educator and Program Director for the Internal Medicine Residency at the Cleveland Clinic Foundation. He serves as faculty at the Cleveland Clinic Lerner College of Medicine and Case Western Reserve University. Previously, Dr. Wardrop was Program Director for the Combined Med-Peds Residency at the University of North Carolina, founding faculty at the Virginia Tech Carilion School of Medicine and founding Associate Dean for Biomedical Affairs at Campbell University School of Osteopathic Medicine. Throughout his career, he has practiced both as an adult and pediatric hospitalist and was recognized by the American College of Physicians (ACP) as one of America's top 10 hospitalists in 2018. He is ABIM Board Certified in Internal Medicine and board certified by the American Board of Pediatrics in Pediatrics. He is the Chair of the ABIM Internal Medicine Board.

Dr. Wardrop has served in national leadership positions within ACP, the Alliance for Academic Internal Medicine (AAIM) and the American Academy of Pediatrics (AAP). He has served as Chair of the Council of Early Career Physicians and as a member of the ACP Board of Regents. He continues on the ACP Education Committee. Within AAIM, he has served on the AAIM Education Committee and the AAIM Graduate Medical Education Funding Task Force, and chaired the AAIM Faculty Development Committee from 2015 to 2017. Within AAP, Dr. Wardrop was a member of the Section of Medicine and Pediatrics Executive Council from 2015 to 2018.

Dr. Wardrop attended Virginia Polytechnic Institute and State University, graduating in 1994 summa cum laude, with honors, in biology before graduating from the Ohio State University with a doctoral degree in molecular virology and immunology in 2000 and his medical degree cum laude in 2002. He completed combined internal medicine and pediatric residency and served as Chief Resident in Internal Medicine at the University of North Carolina at Chapel Hill.

As of September 2024, Dr. Wardrop reported no ongoing external relationships.